FDA. As used herein, “FDA” means the United States Food and Drug Administration, or any successor agency.
Appears in 4 contracts
Samples: Supply and Manufacturing Agreement, Supply and Manufacturing Agreement (Quanterix Corp), Supply and Manufacturing Agreement (Quanterix Corp)
FDA. As used herein, “FDA” means the United States Food and Drug Administration, Administration or any successor agencyagency thereto.
Appears in 4 contracts
Samples: Asset Acquisition Agreement (Panacea Acquisition Corp), Asset Purchase Agreement (Raptor Pharmaceutical Corp), Asset Purchase Agreement (Raptor Pharmaceutical Corp)
FDA. As used herein, “FDA” means shall mean the United States Food and Drug Administration, or any a successor agencyagency thereto.
Appears in 3 contracts
Samples: License Agreement (Discovery Partners International Inc), License Agreement (Discovery Partners International Inc), License Agreement (Infinity Pharmaceuticals, Inc.)
FDA. As used herein, The term “FDA” means shall mean the United States Food and Drug Administration, Administration or any successor agencyentity thereto, and any similar Governmental Authority outside of the United States.
Appears in 3 contracts
Samples: Technology License and Services Agreement (Synaptogenix, Inc.), Technology License and Services Agreement (Neurotrope, Inc.), Technology License and Services Agreement (Neurotrope, Inc.)
FDA. As used herein, “FDA” means the United States Food and Drug Administration, or and any successor agencyagency of the United States government.
Appears in 2 contracts
Samples: Three Way Agreement, Three Way Agreement (Nabriva Therapeutics PLC)
FDA. As used herein, The term “FDA” means shall mean the United States Food and Drug Administration, or any successor agencyagency thereto, having the administrative authority to regulate the marketing of human pharmaceutical products or biological therapeutic products, delivery systems and devices in the United States of America.
Appears in 2 contracts
Samples: Research Funding and Option Agreement (aTYR PHARMA INC), Research Funding and Option Agreement (aTYR PHARMA INC)
FDA. As used herein, “FDA” means the United States Food and Drug Administration, Administration or any successor agency.
Appears in 2 contracts
Samples: Merger Agreement (RayzeBio, Inc.), Agreement and Plan of Merger (Turning Point Therapeutics, Inc.)
FDA. As used herein, The term “FDA” means shall mean the Food and Drug Administration of the United States Food of America and Drug Administration, or any successor agencyagency(ies) or authority having substantially the same function.
Appears in 2 contracts
Samples: Exclusive Research, Development Option and License Agreement (Magenta Therapeutics, Inc.), Exclusive Research, Development Option and License Agreement (Magenta Therapeutics, Inc.)
FDA. As used herein, “The term "FDA” means " shall mean the United States Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
Samples: License and Sub License Agreement (Bioenvision Inc)
FDA. As used herein, “FDA” means the United States Food and Drug Administration, Administration of the United States Department of Health and Human Services or any successor agencyagency thereto.
Appears in 1 contract
Samples: Master Services Agreement (Vickers Vantage Corp. I)
FDA. As used herein, The term “FDA” means the United States Food and & Drug AdministrationAdministration and, or when appropriate herein, shall also mean any successor agencycorresponding regulatory agency in any country.
Appears in 1 contract
FDA. As used herein, “FDA” FDA means the United States Food and Drug Administration, or any successor agencyagency with similar responsibilities.
Appears in 1 contract
FDA. As used herein, “FDA” means the United States Food and Drug AdministrationAdministration of the United States Department of Health and Human Services, or any successor agencyagency thereto.
Appears in 1 contract
Samples: Commercial Manufacturing Services Agreement (Heron Therapeutics, Inc. /De/)
FDA. As used herein, “FDA” means shall mean the United States Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
FDA. As used herein, “FDA” means shall mean the United States U.S. Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
Samples: Stock Purchase Agreement (Aclaris Therapeutics, Inc.)
FDA. As used herein, The term “FDA” means shall mean the United States Food and Drug Administration, or any successor agencyagency thereto.
Appears in 1 contract
FDA. As used herein, “The term "FDA” " means the United States Food and Drug Administration, Administration or any successor agencyentity thereto, including its Center for Biologics Evaluation and Research (CBER).
Appears in 1 contract
